The notices it replaced
- Reissues: PA-20-262 PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 2 steps back: PA-19-273 PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required
- 3 steps back: PA-18-573 PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Replaced by PA-22-177.
Who won it before
301 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $192,329,734 in first-year total cost, median $618,360.
Most frequent study sections
- Special Emphasis Panel[ZRG1 RPHB-Z (10)]45
- Special Emphasis Panel[ZRG1 RPHB-Y (12)]43
- Special Emphasis Panel[ZRG1 RPHB-D (16)]20
- Special Emphasis Panel[ZRG1 CVRS-J (11)]9
- Special Emphasis Panel[ZRG1 ETTN-C (10)]9
Most frequent institutions
- OREGON RES BEHAVIORAL INTERVENTION STRAT10
- MINNESOTA HEALTHSOLUTIONS CORPORATION8
- ISA ASSOCIATES, INC.6
- FLINT REHABILITATION DEVICES5
- POSIT SCIENCE CORPORATION5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | LIGHTSITE IIIB: Clinical Evaluation of Photobiomodulation (PBM) in dry AMD Patients2R44EY025508-04 | TEDFORD, CLARK E | LUMITHERA, INC., WA | $1,169,339 | ZRG1 |
| 2023 | Contact Pathway Inhibitor to Prevent Vascular Access Failure1R44HL167467-01 | LORENTZ, CHRISTINA UTUCKER, ERIK IAN | ARONORA, INC., OR | $998,549 | ZRG1 |
| 2023 | Phase IIB Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease2R44AG047722-07 | LEE, HYUN KYU | POSIT SCIENCE CORPORATION, CA | $924,904 | ZRG1 |
| 2023 | Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy (KneeBRIGHT)2R44AG062069-04A1 | KREPKOVICH, EILEEN T. | BARRON ASSOCIATES, INC., VA | $885,288 | ZRG1 |
| 2023 | Regulatory clearance of the Glide Control Strategy for Upper Limb Prostheses2R44HD090811-04A1 | KALIKI, RAHUL REDDY | INFINITE BIOMEDICAL TECHNOLOGIES, LLC, MD | $873,316 | ZRG1 |
| 2023 | Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes2R44MH114763-02A1 | STERNS, ANTHONY | IRX REMINDER, LLC, OH | $871,153 | ZRG1 |
| 2023 | Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients1R44HL167591-01A1 | GUPTA, DIPANKARSEIGUER, SEBASTIAN | EMOCHA MOBILE HEALTH, INC., MD | $838,636 | ZRG1 |
| 2023 | Novel Post-surgical Incision Management Device to Prevent Ostomy Complications1R44DK131766-01A1 | OBST, ANDREW T | FISTULA SOLUTION CORPORATION, MN | $773,063 | ZRG1 |
| 2023 | Development of an empathetic chatbot to monitor perinatal mental health longitudinally1R43MH130293-01A1 | KERPPOLA, MARIANNAMUZIK, MARIA | POISERA, INC., MI | $431,081 | ZRG1 |
| 2023 | Technology Assisted Treatment for Binge Eating Behavior1R43MH132180-01 | KUMAR, SAMEERPETERSON, CAROL B. | HABITAWARE, INC., MN | $420,178 | ZRG1 |
| 2023 | iKinnect Mobile Technology to Reduce Teen Substance Misuse and Health Disparities1R44DA057122-01 | DIMEFF, LINDA ASCHAEFFER, CINDY M. | EVIDENCE-BASED PRACTICE INSTITUTE, INC., WA | $319,737 | ZRG1 |
| 2023 | Rumbo: An Integrated Mobile and Web-Based Application to Overcome Barriers to Receive Substance Use Disorder (SUD) Treatment and Improve Outcomes for Spanish-Speaking, Hispanic and Latinx Individuals1R43DA057759-01 | CAMPBELL, WILLIAM P | VOLVER HEALTH LLC, NM | $275,743 | ZRG1 |
| 2023 | Clarity in Motion: A Motion-Tolerant Aid for Selectively Hearing Acoustic Sources1R43DC020690-01A1 | GOLDHOR, RICHARD S | SPEECH TECHNOLOGY/APPLIED RESEARCH CORP., MA | $275,389 | ZRG1 |
| 2023 | Fast-Track Multimodal monitoring for neonatal neurocritical care1R44HD107729-01A1 | CARNES, TONY CHRIS | MEDITRACE LLC, FL | $260,434 | ZRG1 |
| 2023 | Humidifeye Plug for Dry Eye Disease1R44EY034758-01 | BAYAT, NIKI | AESCULATECH, INC., CA | $250,487 | ZRG1 |
| 2022 | Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder2R44AA024905-06 · under PA-20-262 | TABAKOFF, BORIS | LOHOCLA RESEARCH CORPORATION, CO | $1,710,532 | ZRG1 |
| 2022 | Augmented Reality Real-Time Guidance for MRI-Guided Interventions2R44EB028722-02A1 | RAJAN, PURNIMA | CLEAR GUIDE MEDICAL, INC., MD | $1,561,929 | ZRG1 |
| 2022 | Labor Status Monitor for diagnosing True versus False Labor in preterm patients1R44HD109107-01 | YOUNG, ROGER C. | PRETEL, INC., TN | $1,375,524 | ZRG1 |
| 2022 | Assessing the Utility of Submaximal Cardiopulmonary Exercise Testing in Diagnosis and Treatment Management of Pulmonary Arterial Hypertension1R44HL162169-01A1 | MACCARTER, DEAN JUDSON | SHAPE MEDICAL SYSTEMS, INC., MN | $1,223,664 | ZRG1 |
| 2022 | Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent1R44CA277890-01 | BENSEN, ERIC SCOTTSINGHAL, SUNIL | VERGENT BIOSCIENCE, INC., MN | $1,124,282 | ZRG1 |
| 2022 | An Open-source Speech Processing Platform (OSP) for Research on Hearing Loss and Related Disorders1R44DC020406-01 | GARUDADRI, HARINATH | NADI LLC, CA | $1,112,006 | ZRG1 |
| 2022 | Evaluation of Subtractive Immunopheresis for Treatment of Hormone-Refractive Advanced Breast Cancer1R44CA261565-01A1 | SHENOUDA, CHRISTIAN | IMMUNICOM, INC., CA | $1,072,330 | ZRG1 |
| 2022 | Development of Sotair for Improving Performance and Minimizing Complications of Manual Ventilation1R44HL165932-01A1 | PRABHUDESAI, PRATHAMESH | SAFEBVM CORP., MO | $1,054,335 | ZRG1 |
| 2022 | Improving the health status of dysvascular amputees by deploying digital prosthetic interface technology in combination with exercise intervention1R44HD110327-01 | BONATO, PAOLOTURNER, TROY | BIONIC SKINS LLC, NH | $1,052,841 | ZRG1 |
| 2022 | Active Disposable Cap for Endoscope Tip Stabilization and Complete Visualization and Dissection of Serrated Sessile Polyps2R44DK117813-06 | MULVIHILL, MAUREEN L. | ACTUATED MEDICAL, INC., PA | $1,047,462 | ZRG1 |
| 2022 | IND‐enabling development of MM‐008 IVR, an antibody-based nonhormonal contraceptive intravaginal ring1R44HD107824-01 · under PA-20-262 | CONE, RICHARD | MUCOMMUNE, LLC, NC | $1,039,122 | ZRG1 |
| 2022 | A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults with Inoperable Relapsed or Refractory High Grade Glioma1R44CA272070-01A1 | LONGCOR, JARRODREILLY, LAURENCE | CELLECTAR BIOSCIENCES, INC., NJ | $1,034,797 | ZRG1 |
| 2022 | Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia2R44CA254560-02 | DILLIGAN, KATE | COOLER HEADS CARE INC, CA | $1,033,003 | ZRG1 |
| 2022 | PROGRESS: PRevention of cervical cancer using the Genotyping scREening and Same-day Self-sampling1R44CA272177-01 | CREMER, MIRIAMWANG, YOUXIANG | ATILA BIOSYSTEMS, INC., CA | $1,011,310 | ZRG1 |
| 2022 | StrokeWear: A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life.2R44HD084035-04 | BONATO, PAOLOKEYSOR, JULIE JVAZIRI, ASHKAN | BIOSENSICS, LLC, MA | $1,008,134 | ZRG1 |
| 2022 | A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location1R44AG076248-01A1 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $1,004,449 | ZRG1 |
| 2022 | Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer1R44CA265626-01A1 | LI, YAJUANTWEEDLE, MICHAEL F | MOLECULAR THERANOSTICS, LLC, OH | $1,000,000 | ZRG1 |
| 2022 | Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients1R44CA272096-01 | DEISHER, THERESA | AVM BIOTECHNOLOGY, LLC, WA | $999,999 | ZRG1 |
| 2022 | Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia1R44CA268530-01A1 | BREITFELD, PHILIPVARADHACHARY, ATUL | FANNIN PARTNERS, LLC, TX | $999,997 | ZRG1 |
| 2022 | Ceraxa (Ceramide NanoLiposome) and Vinblastine For the Improved Treatment of Relapsed or Refractory Acute Myeloid Leukemia1R44CA275609-01 | ADAIR, BERNADETTE MCMAHON | KEYSTONE NANO, INC., PA | $999,628 | ZRG1 |
| 2022 | A treatment drug for triple negative breast cancer1U44CA268345-01A1 | LIU, ZHI-REN | PRODA BIOTECH, LLC, GA | $999,562 | ZRG1 |
| 2022 | The HOPE App: An Immersive Telehealth Solution for Older Adults with Diabetes2R44AG072990-02 | MITCHELL, SUZANNE | SEE YOURSELF HEALTH, LLC, MA | $997,968 | ZRG1 |
| 2022 | Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System1R44DK133084-01 | DEJOURNETT, LEON | IDEAL MEDICAL TECHNOLOGIES, INC., NC | $958,212 | ZRG1 |
| 2022 | Evaluation of the safety and efficacy of non-invasive sonodynamic therapy for diffuse intrinsic pontine glioma1R44CA261516-01A1 · under PA-20-262 | MARCUS, STUART | SONALASENSE INC, CA | $938,955 | ZRG1 |
| 2022 | Knowledge and Usage of Lactation using Education and Advice from Support Network (KULEA-NET)1R44MD016829-01A1 | EVANS, W. DOUGLASMA, TONY XUYENPATCHEN, LORAL | BENTEN TECHNOLOGIES, INC., VA | $915,801 | ZRG1 |
| 2022 | PeriPath: A Single Incision Delivery Tool for Epicardial Pacing and Defibrillation: Phase 21R44HL166048-01 | BERUL, CHARLES IOPFERMANN, JUSTIN | PERICOR, LLC, MD | $914,055 | ZRG1 |
| 2022 | Citizen-Science Technology for Healthy Living at Home2R44MD014915-02 | CARTER, ELLISON MREILLY, THOMAS | ACCESS SENSOR TECHNOLOGIES, LLC, CO | $882,648 | ZRG1 |
| 2022 | Technology Assisted Treatment for Trichotillomania2R44MH114773-03 · under PA-20-262 | FLESSNER, CHRISTOPHER A.KUMAR, SAMEER | HABITAWARE, INC., MN | $879,144 | ZRG1 |
| 2022 | MyRareDiet: A Diet Tracking, Monitoring and Optimization mHealth Solution for Patients with Inborn Errors of Metabolism1R44HD107766-01A1 | HOOK, DEBRA GEARYYANG, DERSHUNG | BRIGHTOUTCOME INC., IL | $870,262 | ZRG1 |
| 2022 | Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women2R44MD015221-02A1 | BILLINGS, DOUGLAS W | ISA ASSOCIATES, INC., VA | $855,861 | ZRG1 |
| 2022 | Phase 1 Study of DNX-2440 for Resectable Colorectal Liver Metastasis - IND 0185691R44CA268421-01A1 | ROBBINS, JOAN MARIE | DNATRIX, INC., CA | $852,568 | ZRG1 |
| 2022 | Modular Convertible Child Safety Seat to Improve Usage2R44HD096963-02A1 · under PA-20-262 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $848,654 | ZRG1 |
| 2022 | Step UP for STEM and Health Careers: An Intervention to Reduce STEM-related biases and improve high school STEM learning environments2R44HD103517-02 · under PA-20-262 | GILLIAM, MELISSA L.HOLL, JANE LOUISEPARSONS, TIMOTHY | RESILIENT GAMES STUDIO, LLC, IL | $834,357 | ZRG1 |
| 2022 | Preventing prescription opioid misuse among employees working in high risk industries.2R44DA050404-02 | HEBARD, STEPHEN | PREVENTION STRATEGIES, LLC, NC | $832,786 | ZRG1 |
| 2022 | Home-Based Parent-Child Intervention to Enhance Executive Function2R44MH121664-02A1 | ANDERSON, SHANE M. | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $811,481 | ZRG1 |
| 2022 | SonoHeal: Smart Resonating Closed-loop Airway Clearance Technology2R44HL152912-02A1 · under PA-20-262 | BISWAS, RAJOSHI | COGNITA LABS, LLC, CA | $780,162 | ZRG1 |
| 2022 | Family Therapy Training and Implementation Platform (FTTIP): An innovative web-based tool for long-term practice improvement2R44MH115547-02 | SANTISTEBAN, DAVID | TRAINING AND IMPLEMENTATION ASSOCIATES, LLC, FL | $752,595 | ZRG1 |
| 2022 | hANDY-i(TM): A non-invasive, dual-sensor handheld imager for intraoperative preservation of parathyroid glands2R44EB030874-02 | CHA, RICHARD JAEPYEONGOH, EUGENERUSSELL, JONATHON O | OPTOSURGICAL, LLC, DE | $749,839 | ZRG1 |
| 2022 | Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)1R44DK131708-01A1 | PERLSTEIN, ETHAN | MAGGIE'S PEARL, LLC, MI | $699,884 | ZRG1 |
| 2022 | Comadres Saludables: A Web-Based Promotora Training Program for Obesity Prevention in Hispanic Women2R44MD016228-02 | RIOS, DEBRA | ISA ASSOCIATES, INC., VA | $697,188 | ZRG1 |
| 2022 | Acuity - A Clinical Decision Support System for Applied Behavior Analysis1R44MH131510-01 | JAKOBOVITS, REX M | EXPERIAD, LLC, HI | $679,957 | ZRG1 |
| 2022 | Ocular Blood Flow Imaging for Glaucoma Assessment1R44EY034064-01 | REGE, ABHISHEK | VASOPTIC MEDICAL, INC., MD | $674,883 | ZRG1 |
| 2022 | Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Based Bladder Permeability Assay2R44DK108397-04 | KAUFMAN, JONATHAN H | LIPELLA PHARMACEUTICALS, INC., PA | $673,049 | ZRG1 |
| 2022 | Adaptive & Individualized AAC2R44DC018437-02A1 | VOJTECH, JENNIFER MICHELE | ALTEC, INC., MA | $575,701 | ZRG1 |
| 2022 | Remote STATE training for Insomnia in Older Adults1R44AG076304-01 · under PA-20-262 | VANVLEET, THOMAS | POSIT SCIENCE CORPORATION, CA | $534,429 | ZRG1 |
| 2022 | Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings1R44CA272095-01 | GOLDBERG, MANIJEH NKEITH, DONNA | PRIVO TECHNOLOGIES, LLC, MA | $401,107 | ZRG1 |
| 2022 | Modulation of cancer induced immune suppression via inhibition of SCD11R44CA272064-01A1 | COPLAND, JOHN A.HAYES, KAREN ETAN, WINSTON | MODULATION THERAPEUTICS, INC., WV | $399,986 | ZRG1 |
| 2022 | EaseAlert: Tactile Firefighter Alerting System Designed to Reduce Negative Cardiovascular Outcomes and Sleep Disturbances1R43HL164225-01A1 | BILLINGS, JOELRICHARDSON, BLAKE | EASEALERT LLC, FL | $384,782 | ZRG1 |
| 2022 | A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis1R44DK133061-01A1 | FANGER, GARY | RISE THERAPEUTICS, LLC, MD | $360,624 | ZRG1 |
| 2022 | Development of novel Aquilo Heat Therapy Device to treat patients with PeripheralArtery Disease1R43HL162337-01A1 | SPENCE, PAUL | AQUILO SPORTS, LLC, KY | $350,681 | ZRG1 |
| 2022 | A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination1R43MH126793-01A1 · under PA-20-262 | BRUNS, ERIC J.DEROSIER, MELISSA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $328,220 | ZRG1 |
| 2022 | Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.1R44DA057133-01 | PERGOLIZZI, JOSEPH V | ENALARE THERAPEUTICS INC., NJ | $319,703 | ZRG1 |
| 2022 | Clinical study of a wearable therapeutic ultrasound sleeve for treatment of neuro-ischemic and ischemic diabetic foot ulcers1R43DK131707-01 · under PA-20-262 | ELSTAD, JULIANA | VIBRATO MEDICAL, INC., CA | $300,000 | ZRG1 |
| 2022 | Improving physical function and quality of life in older adults with prediabetes utilizing interactive small-group resistance training through video conference technology1R44AG076087-01 · under PA-20-262 | LEVITAN, ERICSTARR, KATHRYN N | IMPACTIV, INC., GA | $300,000 | ZRG1 |
| 2022 | Non-invasive therapeutic ultrasound device for treatment of peripheral arterial disease in elderly population1R44AG076190-01A1 | ELSTAD, JULIANA | VIBRATO MEDICAL, INC., CA | $300,000 | ZRG1 |
| 2022 | Smart Technology to Empower Collaborative Partnerships Among Behavior Practitioners and Caregivers to Deliver Quality ABA1R43MH130298-01 | NOSEK, JOHN | GUIDING TECHNOLOGIES CORPORATION, PA | $297,785 | ZRG1 |
| 2022 | Novel Myofunctional Therapy Water Bottle to Reduce Obstructive Sleep Apnea and Snoring1R43HL160368-01A1 · under PA-20-262 | OLMANSON, ANDERS | REMASTERED SLEEP LLC, MN | $293,675 | ZRG1 |
| 2022 | Promoting Linguistic and Cultural Identity through Bilingual Children's Stories to Address Nutrition and Health in Indigenous Communities1R44MD017552-01 | RIESTENBERG, KATHERINE | TRANSCENDENT INTERNATIONAL, LLC, NY | $292,201 | ZRG1 |
| 2022 | Identification of mechanism-based therapies to treat arrhythmogenic cardiomyopathy by resolving perturbations in regulatory lipid signaling1R43HL164226-01 | CORTES-PUCH, IRENE | EICOSIS, LLC, CA | $279,136 | ZRG1 |
| 2022 | Novel Stimulation to Improve Respiratory Function in ARDS and Severe COVID-19 Patients1R43HL162180-01A1 | HARDIN, BILLLU, DANIEL | RESTORE TECHNOLOGIES, INC., CA | $275,405 | ZRG1 |
| 2022 | A Telehealth Intervention to Increase Screening and Treatment for Alcohol Use Disorder1R44AA030702-01 | MENDELSON, JOHN E. | RIA TECHNOLOGY MANAGEMENT INC., CA | $267,065 | ZRG1 |
| 2022 | ID-Cap System: Next generation ingestible sensors for medication adherence measurement1R43NR020289-01A1 | CARNES, TONY CHRISCHAI, PETER R | ETECTRX, INC., FL | $259,270 | ZRG1 |
| 2022 | Access-H20: Sensor driven smart faucet to enable and empower independent drinking and grooming for individuals impacted by spinal cord injury1R43HD108061-01A1 | WADDELL, JOHN STEVEN | NASONI LLC, VA | $259,015 | ZRG1 |
| 2022 | Improving high-risk infant care: from Hospital to Home with Neoneur Telehealth1R44NR020275-01 · under PA-20-262 | HOEDEMAKER, CAROLINE | NEONEUR LLC, NJ | $256,579 | ZRG1 |
| 2022 | A comprehensive web-based program to help advanced cancer patients plan for end of life1R44NR020341-01 · under PA-20-262 | GOOD, JENNIFERSHEN, MEGAN JOHNSON | PEACEFULLY, INC., CA | $256,065 | ZRG1 |
| 2022 | Intervention to Help Orient Men to Excel (IN-HOME): A culturally appropriate CHW training program to reduce minority caregiver burden1R43MD018249-01 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $251,624 | ZRG1 |
| 2022 | Engage-Rx a web-based clinical decision support tool for management of hypertension through patient engagement and automated algorithmic clinical decision support1R43DP006817-01 | FONTIL, VALY | ENGAGE RX, INC., CA | $245,159 | ZRG1 |
| 2022 | Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (EDCs) in Women of Child-Bearing Age and their Partners1R43ES034312-01 | HUA, JENNA | MILLION MARKER WELLNESS INC., CA | $218,790 | ZRG1 |
| 2022 | Civamide Nasal Spray for the Treatment of Dry Eye1R43EY033606-01 · under PA-20-262 | PHILLIPS, SCOTT | ELORAC, INC., IL | $160,284 | ZRG1 |
| 2022 | Joyuus: A Web-based Tool for Postpartum Care Self-care to Address the Complex Needs of Underserved Women2R44MD014923-02 | MARCEAU, LISA DMERZ, KRISTINE | ORANGE SQUARE DESIGN, INC., RI | $1 | ZRG1 |
| 2021 | Using Clinical Treatment Data in a Machine Learning Approach for Sepsis Detection2R44AA030000-02 · under PA-20-262 | HOFFMAN, JANA | DASCENA, INC., CA | $1,999,554 | ZRG1 |
| 2021 | Clinical Trial and Commercialization of a Wearable Therapeutic Ultrasound Device for Peripheral Arterial Disease1R44HL156543-01 · under PA-19-273 | DAW, DEREK | VIBRATO MEDICAL, INC., CA | $1,500,000 | ZRG1 |
| 2021 | Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial1R44HL158376-01 · under PA-20-262 | JEONG, SUN YONGREED, GUY LTAPSON, VICTOR F. | TRANSLATIONAL SCIENCES, INC., AZ | $1,408,991 | ZRG1 |
| 2021 | Assessing the safety and efficacy of SQ3370 in a phase 1b dose-expansion cohort at the recommended Phase 2 dose in patients with advanced sarcoma1R44CA265665-01 · under PA-20-262 | MEJIA ONETO, JOSE M | SHASQI, INC., CA | $1,376,786 | ZRG1 |
| 2021 | A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients1R44DK130778-01 · under PA-20-262 | DESHAYES, STEPHANIE | TEMPO THERAPEUTICS, INC., CA | $1,368,090 | ZRG1 |
| 2021 | Immune Biomarker Assessment and Manufacturing Development for SQ3370-001, a first-in-human phase I dose-escalation clinical trial to test a novel treatment against advanced solid tumors1R44CA261573-01 · under PA-20-262 | MEJIA ONETO, JOSE M | SHASQI, INC., CA | $1,198,848 | ZRG1 |
| 2021 | Manganese Based MRI Contrast Agent - First In Human Clinical Trial1R44CA268392-01 · under PA-20-262 | HOFFMAN, VERA | REVEAL PHARMA, MA | $1,149,940 | ZRG1 |
| 2021 | Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy1R44CA265565-01 · under PA-20-262 | HANSEN, ANGELA | WINSANTOR, INC., CA | $1,101,366 | ZRG1 |
| 2021 | Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer1R44CA257278-01A1 · under PA-20-262 | PACK, CHRISTOPHER D | METACLIPSE THERAPEUTICS CORPORATION, GA | $1,061,403 | ZRG1 |
| 2021 | Randomized phase II study of TheraBionic in advanced hepatocellular carcinoma1R44CA256984-01A1 · under PA-20-262 | PASCHE, VALERIE | THERABIONIC INC., NC | $1,059,091 | ZRG1 |
| 2021 | QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast Cancer1R44CA257579-01A1 · under PA-20-262 | RINGOLD, GORDON M | QUADRIGA BIOSCIENCES, INC., CA | $1,053,136 | ZRG1 |
| 2021 | Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa1R44CA265656-01 · under PA-20-262 | POTASEK, MARYSHAFIRSTEIN, GAL | SIMPHOTEK, INC., NJ | $1,050,000 | ZRG1 |
| 2021 | Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting1R44DK131700-01 · under PA-20-262 | HERRERA, DEREK | BRIGHT URO, INC., CA | $999,992 | ZRG1 |
| 2021 | A Phase 1, Open Label, Multicenter Trial to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients with Relapsed or Refractory CD20+ B-Cell NHL or CLL1R44CA265616-01 · under PA-20-262 | LITCHMAN, MANUEL | MUSTANG BIO, INC., MA | $999,336 | ZRG1 |
| 2021 | Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distress Syndrome1R44HL158446-01 · under PA-20-262 | STEWART, CHARLES ANDREW | CARTESIAN THERAPEUTICS, INC., MD | $998,742 | ZRG1 |
| 2021 | Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder1R44DK129164-01A1 · under PA-20-262 | GAD, PARAG | SPINEX, INC., CA | $956,407 | ZRG1 |
| 2021 | Electrical stimulation to reduce pain and improve function after knee replacement2R44AG052196-04A1 · under PA-20-262 | BOGGS, JOSEPH WILDER | SPR THERAPEUTICS, LLC, OH | $954,397 | ZRG1 |
| 2021 | IndieTrainer: Enabling Children with Cerebral Palsy to Receive Gamified Power Mobility Training in their Own Manual Wheelchairs1R44HD103522-01A1 · under PA-20-262 | ZONDERVAN, DANIEL | FLINT REHABILITATION DEVICES, CA | $954,242 | ZRG1 |
| 2021 | Soft Spring Continence Pessary for Women1R44HD105574-01 · under PA-20-262 | GAUPP, CHRISTINAROBERTS, MELODY ANN | LIV LABS INC., IL | $951,491 | ZRG1 |
| 2021 | Zip-stitch for Laparoscopic Hysterectomy - Clinical Validation1R44HD104539-01A1 · under PA-20-262 | MAZZUCCO, DAN C | ZSX MEDICAL, LLC, PA | $928,014 | ZRG1 |
| 2021 | Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder2R44AA027188-02 · under PA-20-262 | BATKI, STEVEN LBURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $910,489 | ZRG1 |
| 2021 | Fostering Caregiver Connections via Intentional Technology Pairing for Caregivers of Patients with Alzheimer's Disease and Other Types of Dementia2R44AG065088-02 · under PA-20-262 | KRAMER, KEVIN M. | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $909,966 | ZRG1 |
| 2021 | Assistive ExoSkeleton and ExoTendon System for Increased Return of Limb Function after Diabetic Foot Ulcer1R44NR019969-01 · under PA-20-262 | ROSER, MARK C | RESULTS GROUP, CT | $870,416 | ZRG1 |
| 2021 | Boost: A pragmatic inpatient rehabilitation strategy for improving musculoskeletal arm recovery after stroke1R44HD106850-01 · under PA-20-262 | ZONDERVAN, DANIEL | FLINT REHABILITATION DEVICES, CA | $868,802 | ZRG1 |
| 2021 | DreamPort-Eclipse: Compact, ultra-low contact, custom fit CPAP human interface solution for obstructive sleep apnea1R44HL158286-01A1 · under PA-20-262 | HEATHERINGTON, STUART | BLEEP, LLC, NC | $860,622 | ZRG1 |
| 2021 | Safety-Enhancing Motor Vehicle Child Safety Seat2R44CE003388-02 · under PA-20-262 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $846,699 | ZRG1 |
| 2021 | Socializing a Science-based Digital Therapeutic for Substance Use Disorders2R44DA047150-02 · under PA-20-262 | GRABINSKI, MICHAEL JOHN | SQUARE2 SYSTEMS, INC., NH | $836,571 | ZRG1 |
| 2021 | Utility of Esophageal Cooling Therapy for the Prevention of Thermal Injury During Atrial Fibrillation1R44HL158375-01 · under PA-20-262 | KULSTAD, ERIK BENJAMINSANTANGELI, PASQUALETSCHABRUNN, CORY MICHAEL | ADVANCED COOLING THERAPY, LLC, IL | $800,000 | ZRG1 |
| 2021 | An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia1R44CA265558-01 · under PA-20-262 | FRIEND, JOHNLONGCOR, JARROD | CELLECTAR BIOSCIENCES, INC., NJ | $763,080 | ZRG1 |
| 2021 | RT Assistant - handheld patient safety tool for mechanical ventilation2R44HL146012-02A1 · under PA-20-262 | EULIANO, NEIL R. | CONVERGENT ENGINEERING, INC., FL | $756,143 | ZRG1 |
| 2021 | Ambient light activatable opsin based therapy for age-related macular degeneration2R44EY025905-04 · under PA-20-262 | MOHANTY, SAMARENDRA KUMAR | NANOSCOPE TECHNOLOGIES, LLC, TX | $749,517 | ZRG1 |
| 2021 | A Video-Based mHealth Program to Support People Living with HIV Across the HIV Care Continuum2R44MD013644-02 · under PA-19-273 | MONTOYA, JORGE ALEJANDRO | SENTIENT RESEARCH, INC., CA | $744,090 | ZRG1 |
| 2021 | Reducing Colorectal Cancer Health Disparities: An mHealth Intervention to Improve Screening among African American Men2R44CA246899-02A1 · under PA-20-262 | LEAF, SAMANTHA L. | ISA ASSOCIATES, INC., VA | $723,593 | ZRG1 |
| 2021 | Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation1R44DC019586-01 · under PA-20-262 | KING, CURTIS SCOTTRAJGURU, SUHRUD M. | RESTOREAR DEVICES, LLC, MT | $712,765 | ZRG1 |
| 2021 | Strengthening Families Program Online for Teens and Families2R44DA046238-02A1 · under PA-19-273 | KUMPFER, KAROL L. | STRENGTHENING FAMILIES PROGRAM, LLC, UT | $682,065 | ZRG1 |
| 2021 | Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders2R44MD014113-02 · under PA-20-262 | DONENBERG, GERI RFEIL, EDWARD GUSTAVSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $675,605 | ZRG1 |
| 2021 | Assist-Knee: Energy Harvesting for Sit-to-Stand-to-Sit Transitions2R44HD097826-02A1 · under PA-20-262 | CHANG, SARAH | ORTHOCARE INNOVATIONS, LLC, WA | $665,414 | ZRG1 |
| 2021 | Diabetes Prevention for Hispanics Residing in Rural Communities: A Mobile Web-based Approach2R44MD014082-02A1 · under PA-20-262 | RIOS, DEBRA | ISA ASSOCIATES, INC., VA | $661,086 | ZRG1 |
| 2021 | Interactive Training Tool Providing Technique Feedback for COPD Medication Delivery1R44AG071430-01 · under PA-19-273 | LICHTER, PATRICK | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $618,070 | ZRG1 |
| 2021 | Clinical Feasibility Study of a Novel Flexible, Non-occlusive GERD Treatment Device1R44DK127882-01A1 · under PA-20-262 | TIHON, CLAUDE NMN | APLOS MEDICAL INC, MN | $596,460 | ZRG1 |
| 2021 | SkillTalk: Communication Training around Sexual Health Topics for Parents of Youth with Autism Spectrum Disorder2R44HD097906-02A1 · under PA-20-262 | FIRPO-TRIPLETT, REGINA | DFUSION, INC., CA | $587,743 | ZRG1 |
| 2021 | Kidney Support in Pediatric Patients Using an Ultrafiltration Device1R44DK127631-01A1 · under PA-20-262 | KNUESEL, ROBERT J | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $567,212 | ZRG1 |
| 2021 | Targeted alpha-emitter therapy of patients with PRRT refractory neuroendocrine tumors1R44CA265421-01 · under PA-20-262 | TWOROWSKA, IZABELA | RADIOMEDIX, INC., TX | $548,182 | ZRG1 |
| 2021 | Disease Modifying Treatment for Hemolytic Disorders1R44HL156774-01A1 · under PA-20-262 | BANSAL, REKHA | NOVELMED THERAPEUTICS, INC., OH | $533,165 | ZRG1 |
| 2021 | Intestinal Lengthening via Distraction Enterogenesis for the Treatment of Short Bowel Syndrome1R44DK127658-01A1 · under PA-20-262 | BESSETTE, ANDRE | ECLIPSE ENTEROGENESIS, INC., CA | $423,221 | ZRG1 |
| 2021 | Furthering the clinical development of a first in class, water resistant sunscreen to meet emerging environmental regulations1R43CA257692-01A1 · under PA-20-262 | ISAACMAN, STEVEN | NANOMETICS, LLC, CA | $398,768 | ZRG1 |
| 2021 | Treating Drivers of Suicide in Primary Care using Jaspr Health1R44AA029868-01 · under PA-20-262 | DIMEFF, LINDA AJOBES, DAVID ALAN | EVIDENCE-BASED PRACTICE INSTITUTE, INC., WA | $397,990 | ZRG1 |
| 2021 | Personal relevance of psychotherapy for Asian Americans: A mHealth problem-solving intervention to reduce stress (PRoP-AA)1R44MH125698-01A1 · under PA-20-262 | HALL, GORDON C. NAGAYAMAMONROE, TERRIEWENDT, ADAM JOHN | IRIS MEDIA, INC., OR | $381,931 | ZRG1 |
| 2021 | FHIR-ed Up for Tobacco Cessation1R43HL156588-01A1 · under PA-19-273 | JOHNSON, SARA S | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $378,553 | ZRG1 |
| 2021 | Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers1R43DA053121-01A1 · under PA-20-262 | PERSE, ARTIN | PILLSMART INC., NY | $324,072 | ZRG1 |
| 2021 | A Digital Therapeutic for Pain Relief through AI-Guided Visual Stimulation1R43DA054845-01 · under PA-20-262 | HANINA, ADAM | DANDELION SCIENCE CORP, NY | $319,489 | ZRG1 |
| 2021 | WayToServe Plus: In-service Professional Development Component to Improve Responsible Alcohol Service1R44AA029364-01 · under PA-20-262 | BULLER, DAVID BWOODALL, W GILL | KLEIN BUENDEL, INC., CO | $314,423 | ZRG1 |
| 2021 | Additive Manufacturing of Patient-Specific Masks and Nasal Prongs to Improve Pediatric Ventilation Outcomes and Reduce Pressure Sores1R44HD105552-01 · under PA-20-262 | BAGWELL, ROGER BROOKS | ACTUATED MEDICAL, INC., PA | $309,518 | ZRG1 |
| 2021 | Demonstration of a Digital Care Program for Methamphetamine Use Disorder1R43DA055394-01 · under PA-20-262 | MUHLNER, KRISTIN | AFFECT THERAPEUTICS, INC., NY | $309,360 | ZRG1 |
| 2021 | Empower Neuromodulation System, a home-use device for the treatment of anxiety disorders1R43AT011497-01 · under PA-20-262 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $302,951 | ZRG1 |
| 2021 | Novel On Demand Female Oral Contraceptive1R43HD104508-01 · under PA-19-273 | ARCHER, DAVID FITZGERALD | INNOVAGYN, INC., VA | $300,001 | ZRG1 |
| 2021 | Reducing time to heal chronic leg wounds through monitoring, engagement and intelligent intervention via WoundAlert system1R43AG074834-01 · under PA-20-262 | ENGEL, JONATHAN M | SURAMEDICAL, LLC, MN | $299,977 | ZRG1 |
| 2021 | A Fully Remote Telehealth Brain Computer Interface And Assessment System For Motor Rehabilitation Of Chronic Stroke1R44HD105579-01 · under PA-20-262 | BHUGRA, KERN | NEUROLUTIONS, INC, CA | $299,891 | ZRG1 |
| 2021 | Toward development of a comprehensive, in-home, active seating system to lessen sedentariness and improve health and wellness in older adults.1R43AG074697-01 · under PA-20-262 | LEIB, ROGERNIEMIEC, STACEY LYNN SCHEPENS | ACTIV SITTING, INC., CA | $291,700 | ZRG1 |
| 2021 | SSW Works: A Virtual Learning Environment for Occupational Skin Cancer Prevention1R44CA257778-01A1 · under PA-20-262 | BULLER, MARY K | KLEIN BUENDEL, INC., CO | $263,012 | ZRG1 |
| 2021 | A Novel Device for Training and Evaluating Ultrasound-Guided Procedures In Anesthesia1R43GM144333-01 · under PA-20-262 | RAJAN, PURNIMA | CLEAR GUIDE MEDICAL, INC., MD | $259,613 | ZRG1 |
| 2021 | Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD)1R43CE003533-01 · under PA-20-262 | ROSLYAKOV, STANISLAV | ADDINEX TECHNOLOGIES, INC., NY | $259,559 | ZRG1 |
| 2021 | Developing the Unified Protocol-Single Session Experience Platform for Adolescent Mental Health1R43MH128075-01 · under PA-20-262 | DEROSIER, MELISSA E.EHRENREICH-MAY, JILLSCHLEIDER, JESSICA LEE | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $259,291 | ZRG1 |
| 2021 | Interactive Digital Media-based Learning for Hand Hygiene in School-Age Children1R43GM144007-01 · under PA-20-262 | CRILEY, JASMINKA | INDELIBLE LEARNING, INC., CA | $256,579 | ZRG1 |
| 2021 | Walk with Me (WWM) for Perinatal Grief1R43MH126788-01A1 · under PA-20-262 | CIOFFI, CAMILLE CSCHWEER-COLLINS, MARIASMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $256,501 | ZRG1 |
| 2021 | Digital health for medication adherence among African Americans with hypertension1R43MD015969-01A1 · under PA-20-262 | WEITZMAN, PATRICIA FLYNN | ENVIRONMENT AND HEALTH GROUP, INC., MA | $256,460 | ZRG1 |
| 2021 | Integrated Smart Speaker/Mobile Application to Promote Positive Parenting Among Caregivers of Youth with Challenging Behaviors1R43MH124577-01A1 · under PA-20-262 | FEIL, EDWARD GUSTAVMETZLER, CAROL WSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $256,429 | ZRG1 |
| 2021 | Novel Pediatric Endotracheal Tube Securement System1R44HD103566-01A1 · under PA-20-262 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $256,216 | ZRG1 |
| 2021 | Remote Digital Health Intervention to Improve Balance and Reduce Fall Risk1R43AG074833-01 · under PA-20-262 | VANVLEET, THOMAS | POSIT SCIENCE CORPORATION, CA | $254,947 | ZRG1 |
| 2021 | FitMi PD: an affordable home therapy device for individuals with Parkinson's disease1R43AG071253-01 · under PA-19-273 | RUSSELL, IAN MILES | FLINT REHABILITATION DEVICES, CA | $252,132 | ZRG1 |
| 2021 | Point of Care Lung CT for Patients with Acute Respiratory Failure1R44HL158452-01 · under PA-20-262 | VANKAMPEN, WILLIAM CHARLES | XORAN TECHNOLOGIES, LLC, MI | $252,124 | ZRG1 |
| 2021 | An online professional development course to train CHWs to provide oral health outreach to low-income Black guardians1R43MD016352-01 · under PA-20-262 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $251,032 | ZRG1 |
| 2021 | Natural Sleep Endoscopy system for obstructive sleep apnea: improving the measurement of pattern of airway obstruction and treatment outcomes1R43HL154958-01A1 · under PA-19-273 | KEZIRIAN, ERIC JAMES | BERENDO SCIENTIFIC, LLC, CA | $246,784 | ZRG1 |
| 2021 | NON-INVASIVE WRIST-WATCH DEVICE FOR REMOTE MONITORING OF HEART FAILURE PATIENTS1R43HL156691-01A1 · under PA-20-262 | MERCHANT, MARIA | INCARDIA INC., CA | $224,700 | ZRG1 |
| 2021 | Increasing Health Equity Through In-The-Moment Reading Assistance for Adults with Diabetes Served at Community Health Centers1R43NR020340-01 · under PA-20-262 | SHIPPEE, NATHAN DZIMMERMAN-BENCE, NED | GOGYUP, INC., MN | $200,000 | ZRG1 |
| 2020 | Noninvasive multiphoton imaging of subcellular structures with color contrast for rapid detection of skin cancers2R44CA221591-02A1 · under PA-18-573 | SANCHEZ, GABRIEL NESTOR | ENSPECTRA HEALTH, INC., CA | $1,944,985 | ZRG1 |
| 2020 | Novel Therapy System for Atrial Fibrillation1R44HL154937-01 · under PA-19-273 | BOURN, DAVID W | CARDIALEN, INC., MO | $1,605,396 | ZRG1 |
| 2020 | Daily & Localized NSAID Sonophoresis for Symptomatic Treatment of Knee Osteoarthritis2R44AG061985-03 · under PA-19-273 | LEWIS, GEORGE KENNETH | ZETROZ SYSTEMS, LLC, CT | $1,442,543 | ZRG1 |
| 2020 | Clinical performance of hemodynamics-based non-invasive device for skin cancer testing1R44CA250768-01 · under PA-19-273 | CHACHISVILIS, MIRIANAS | VERISKIN, INC., CA | $1,164,975 | ZRG1 |
| 2020 | Vibration-integrated Lancing System to Reduce Stress, Pain Response, Heel Damage and Developmental Harm from Recurring Heel Sticks in Neonates2R44HD088139-02A1 · under PA-19-273 | CLEMENT, RYAN S | ACTUATED MEDICAL, INC., PA | $1,136,037 | ZRG1 |
| 2020 | Non-clinical Combination Pharmacology Studies and Phase 1 Clinical Development of IO-202 in Acute Myeloid Leukemia (AML)1R44CA250543-01A1 · under PA-19-273 | LIAO, CHARLENE | IMMUNE-ONC THERAPEUTICS, INC., CA | $1,070,000 | ZRG1 |
| 2020 | Health in Motion- A Pragmatic Clinical Trial2R44AG043191-04A1 · under PA-19-273 | FLYNN, SHERYL | BLUE MARBLE REHAB, INC., CA | $1,014,720 | ZRG1 |
| 2020 | Randomized Prospective Trial of Breast Cancer Locator Guided vs. Wire Localized Partial Mastectomy for Breast Cancer1R44CA247124-01A1 · under PA-19-273 | KRISHNASWAMY, VENKATARAMANAN | CAIRNSURGICAL, INC., NH | $1,007,656 | ZRG1 |
| 2020 | Long-acting PTH for hypoparathyroidism2R44DK107231-04 · under PA-19-273 | HALES, LAURA M | EXTEND BIOSCIENCES, INC., MA | $1,000,000 | ZRG1 |
| 2020 | Novel Expandable Infusion Catheter for the Treatment of Acute Pulmonary Embolism1R44HL151032-01 · under PA-18-573 | FIRTH, BRIAN GARRIOCK | THROMBOLEX, INC., PA | $999,997 | ZRG1 |
| 2020 | A Bullet Proof vascular graft to prevent dialysis access cannulation injury2R44DK108488-04A1 · under PA-19-273 | KNIGHT, JOSEPH | INNAVASC MEDICAL, INC., NC | $999,841 | ZRG1 |
| 2020 | Non-surgical treatment option for pelvic organ prolapse2R44HD097809-02 · under PA-18-573 | HANISSIAN, PAUL | REIA, LLC, NH | $994,018 | ZRG1 |
| 2020 | Phase 1/2 Clinical Study of Humanized Anti-BCMA CAR T Cells in Relapsed/Refractory Multiple Myeloma (MM)2R44CA221432-02A1 · under PA-19-273 | STEWART, CHARLES ANDREW | CARTESIAN THERAPEUTICS, INC., MD | $988,226 | ZRG1 |
| 2020 | Development of 7HP349, an oral integrin activator to enhance therapeutic responses to immune checkpoint inhibitors1R44CA250646-01A1 · under PA-19-273 | LEWIS, LIONEL DAVIDMARATHI, UPENDRA | 7 HILLS PHARMA, LLC, TX | $984,409 | ZRG1 |
| 2020 | Automating and Obtaining FDA Approval for a Digital Intervention for Depression2R44MH113520-03 · under PA-19-273 | FRANK, ELLEN | HEALTH RHYTHMS, INC., NY | $974,672 | ZRG1 |
| 2020 | Talk STEM Familia: Dual-Language Academic Vocabulary-Building Technology to Improve Educational, Career, and Health Outcomes Among Latinx Students2R44MD013619-02 · under PA-19-273 | MARQUEZ, JESSIEVADASY, PATRICIA F | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $965,354 | ZRG1 |
| 2020 | Development of Ciclopirox Prodrug as a Novel Systemic Treatment for High-Risk Non-Muscle Invasive Bladder Cancer1R44CA246997-01A1 · under PA-19-273 | MC CULLOCH, WILLIAMWEIR, SCOTT JAMES | CICLOMED, LLC, MO | $936,240 | ZRG1 |
| 2020 | Phase 2 Clinical Trial Evaluating a Novel Therapy in Patients who are Post-lung Transplant1R44HL151144-01A1 · under PA-19-273 | COPELAND, DANIEL W.DURHAM, CAROLYN | RENOVION, INC., NC | $920,791 | ZRG1 |
| 2020 | The Use of Photobiomodulation (PBM) in the Treatment for Diabetic Macular Edema2R44EY025892-02A1 · under PA-19-273 | TEDFORD, CLARK E | LUMITHERA, INC., WA | $897,302 | ZRG1 |
| 2020 | Video-Based Microskills Training Intervention to Improve Health Education to Reduce Risk Behaviors in Youth1R44HD102288-01A1 · under PA-19-273 | FIRPO-TRIPLETT, REGINAKUHN, TAMARA J. | DFUSION, INC., CA | $885,147 | ZRG1 |
| 2020 | Assessing the impact of app-delivered lighting interventions on fatigue in three populations of cancer patients2R44CA236557-02A1 · under PA-19-273 | WALCH, OLIVIA | ARCASCOPE, INC, VA | $873,205 | ZRG1 |
| 2020 | Middle-ear reflex testing using wideband acoustic immittance2R44DC016780-02 · under PA-19-273 | HOOD, LINDA J.JENG, PATRICIA S | MIMOSA ACOUSTICS, IL | $866,153 | ZRG1 |
| 2020 | Novel, Non-Toxic Ocular Antiseptic For Intravitreal Injection Therapy1R44EY031206-01 · under PA-18-573 | CHALBERG, THOMAS WSMITH, STEPHEN J | IRENIX MEDICAL, INC., CA | $847,954 | ZRG1 |
| 2020 | Applying Technology-Enabled Contingency Management for Alcohol Use Disorder At Scale in a Medicaid Population2R44AA026234-02 · under PA-19-273 | GASTFRIEND, ERIC ELIAS | DYNAMICARE HEALTH, INC., MA | $828,764 | ZRG1 |
| 2020 | Nutritional Stimulation of Muscle Protein Synthesis and Metabolic Rate After Bariatric Surgery1R44DK125151-01 · under PA-19-273 | WOLFE, ROBERT R | AMINO COMPANY LLC, THE, DE | $806,481 | ZRG1 |
| 2020 | A Technology-Based Novel Functional Skills Assessment and Training Program for Adults with and without Cognitive Impairments. Develop the next generation software solution.2R44AG057238-03A1 · under PA-19-273 | KALLESTRUP, PETER | I-FUNCTION, INC., FL | $802,500 | ZRG1 |
| 2020 | Reducing Health Disparities among African American Women: A Mobile Cognitive Behavioral Stress Management Intervention2R44MD014077-02 · under PA-19-273 | BILLINGS, DOUGLAS W | ISA ASSOCIATES, INC., VA | $801,362 | ZRG1 |
| 2020 | Motivating Occupational Virtual Experiences In Therapy for kids2R44HD092169-02A1 · under PA-19-273 | ADAMS, RICHARD J. | BARRON ASSOCIATES, INC., VA | $777,739 | ZRG1 |
| 2020 | Percutaneous Ultrasound Gastrostomy: Clinical Evaluation of a Feeding Tube Placement Method in the Pediatric Population2R44DK123910-02A1 · under PA-19-273 | CAROLAN, HOWARD | COAPTECH, LLC, MD | $768,234 | ZRG1 |
| 2020 | A Novel Orogastric/Nasogastric Feeding Tube for Optimizing Nutritional Administration in the Neonatal Intensive Care Unit Population2R44HD098938-02A1 · under PA-19-273 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $765,005 | ZRG1 |
| 2020 | Interactive Cognitive Behavioral Therapy for Insomnia2R44CA232905-02A1 · under PA-19-273 | AREM, HANNAHGREENBERG, DANIEL J | MEDIA REZ, LLC, DC | $756,832 | ZRG1 |
| 2020 | A ratcheting prosthetic partial finger using advanced rapid manufacturing technology2R44HD096942-02A1 · under PA-19-273 | SLIKER, LEVIN | POINT DESIGNS, LLC, CO | $749,508 | ZRG1 |
| 2020 | Multi-Media Parent-based Intervention to Promote Dental Hygiene Among Young Children: BeReady2Smile2R44DE027001-02A1 · under PA-18-573 | FEIL, EDWARD GUSTAVSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $746,784 | ZRG1 |
| 2020 | Effects of the Next Generation TNF Inhibitor (XPro1595) on Inflammation-related Deficits in Reward Circuitry and Motivation in Depression1R44MH125480-01 · under PA-19-273 | BARNUM, CHRISTOPHER J | INMUNE BIO, INC., FL | $739,739 | ZRG1 |
| 2020 | An additive solution optimized for anaerobic (hypoxic) RBC storage to minimize storage lesion development.1R44HL149579-01A1 · under PA-18-573 | NEMKOV, TRAVISYOSHIDA, TATSURO | NEW HEALTH SCIENCES, INC., MA | $721,856 | ZRG1 |
| 2020 | A system and process to improve the satisfaction with hearing health products1R44DC019072-01A1 · under PA-19-273 | CONDON, JOHN PAUL | INNOVATIVE DESIGN LABS, INC., MN | $712,183 | ZRG1 |
| 2020 | A Phase 3 Multicenter, Randomized, Vehicle-Controlled Clinical Study to Evaluate the Safety and Efficacy of an Ophthalmic Emulsion of Nintedanib in Pterygium Patients2R44EY028784-04A1 · under PA-19-273 | YANG, RONG | CLOUDBREAK THERAPEUTICS, LLC, CA | $699,988 | ZRG1 |
| 2020 | Continuous wearable monitor for the detection and release of Freezing of Gait2R44AG057263-02 · under PA-19-273 | CONDON, JOHN PAUL | INNOVATIVE DESIGN LABS, INC., MN | $699,236 | ZRG1 |
| 2020 | Wearable Transcutaneous Electrical Acustimulation for Gastroparesis1R44AT011380-01A1 · under PA-19-273 | YIN, JIEYUN NONE | TRANSTIMULATION RESEARCH, INC., OK | $618,361 | ZRG1 |
| 2020 | Optimized Medial Olivocochlear Reflex Screening and Testing Module1R44DC018491-01A1 · under PA-19-273 | DELGADO, RAFAEL E | INTELLIGENT HEARING SYSTEMS, FL | $618,360 | ZRG1 |
Showing the 200 most recent of 301 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.